BioSpace News Archive

Business

Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories

Under the amended collaboration agreement, studies will be conducted to generate and evaluate semi-synthetic cytisine derivatives for potential use in multiple indications across addiction and neurological disorders.

January 24, 2018
·
5 min read
Business

Cardiovascular Systems Names Former Medtronic Exec as COO

Robb will report to Scott Ward, CSI Chairman, President and Chief Executive Officer.o

January 24, 2018
·
2 min read
Biotech Beach

Aerie Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Aerie today announced that it has priced its registered underwritten public offering of $75 million of shares of its common stock.

January 24, 2018
·
4 min read
Business

Inge Thulin Elected to Merck Board of Directors

Mr. Thulin will stand for election with the company’s other directors in connection with Merck’s Annual Meeting of Shareholders on May 22, 2018.

January 24, 2018
·
4 min read
CureVac Expands Intellectual Property Position That Significantly Improves Protein Expression for Its mRNA-Based Vaccines and Therapeutics

CureVac announced that the United States Patent and Trademark Office and the European Patent Office have granted or respectively intend to grant multiple composition of matter patents for CureVac’s mRNA technology.

January 24, 2018
·
3 min read
Business

Imprimis Pharma is Issued DEA Manufacturer Certificate for its 503B Outsourcing Facility

This new registration will further allow Imprimis to leverage its national compounding platform and its relationships with nearly 2,000 ophthalmology and optometric customers.

January 24, 2018
·
3 min read
FDA

Perrigo Announces Final FDA Approval and Launch of an AB Rated Generic Version of Epiduo Gel

Perrigo today announced it has received final approval from the FDA and has launched an AB rated generic version of Epiduo Gel, 0.1%/2.5%.

January 24, 2018
·
4 min read
Business

Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2017

Enanta today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2017, after the U.S. markets close on February 7, 2018.

January 24, 2018
·
2 min read
Policy

NIH Gets Into CRISPR/Cas9, Launches $190M Genome Editing Research Program

Somatic Cell Genome Editing aims to develop tools for safe and effective genome editing in humans.

January 24, 2018
·
3 min read
FDA

Perrigo Announces Final FDA Approval of a Generic Version of Estrace Cream

This product will be marketed by Perrigo’s partner, Impax, and is currently expected to launch in the second quarter of this year.

January 24, 2018
·
4 min read